AboutContact us
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
“Other countries have air-defense systems, but Israel’s are better”: Arrow 3 lands in Germany as Israel pursues new mega deals
2
Unit 8200 veterans raise $22 million Series A for real-time impersonation defense
3
Cybereason founders' 7AI raises record $130 million Series A in breakneck rise
4
Check Point raises $1.75 billion, potentially eyeing AI expansion
5
Nice puts Actimize up for sale at a $1.5-2 billion price tag
More news

Biotech

20 stories about Biotech
נאסדק

Teva-Linked Biotech Company 89Bio Files for Nasdaq IPO

15.10.19|CTech
Israel and San Francisco-based 89Bio raised a $60 million series A in October 2018
פנאי נתח בשר

Ophectra Signs Merger Deal With Meat Bioprinting Company MeaTech

03.10.19|Ori Galor and Tzally Greenberg
The announcement comes a week after Ophectra announced that its merger deal with cannabis company Hi Pharma fell through
בורסה בורסת תל אביב 5

New York-Based Financial Services Firm Jefferies to Join Tel Aviv Stock Exchange

02.06.19|Raheli Bindman
As a remote member, Jefferies’ international clients will gain better access to Israeli tech and biotech companies, creating more investment opportunities
שם: מעבדה ביוטק וושי אפטק Lab Biotech WuXi AppTec

RM Global Raises Additional $34 Million for Israel-Based Biopharma Investment Fund

09.04.19|CTech
The fund's portfolio is made up of 11 startups operating at the company’s FutuRx biotech accelerator in the central Israeli town of Ness Ziona
מוסף רפואה מבחנה מבחנות תרופה תרופות בית חולים

Can-Fite BioPharma to Raise $3.2 Million in Direct Offering

04.04.19|CTech
The NYSE and Tel Aviv-listed company develops small molecule drugs used in the treatment of liver and inflammatory diseases and cancer
נאסדק

Cell Immunotherapy Company Enlivex Merges With Nasdaq-Listed Bioblast, Raises $5.3 Million

28.03.19|Lilach Baumer
The merged entity listed on Nasdaq under the ticker “ENLV”
נאסד"ק וול סטריט

Anchiano Therapeutics Stock Falls on Nasdaq IPO

13.02.19|Lilach Baumer
The cancer treatment company priced its ADSs at $11.5 per unit, expecting proceeds of $30.5 million
נאסדק

Cancer Screening Company Check-Cap Crashes on $7.5 Million Nasdaq Direct Offering

05.02.19|Lilach Baumer
The clinical-stage company announced the discounted offering Monday, closing 27.62% down on the exchange
בריאות דיגיטלית מדעי החיים רפואה טיפול 1

Pfizer Taps Israeli Machine Learning Drug Discovery Company CytoReason

10.01.19|Lilach Baumer
Under the agreement, CytoReason will receive payments "potentially equaling up to low double digit millions" of dollars
חברת תרופות סלג'ן סלג'ין Celgene משרדים סן דייגו קליפורניה

Celgene Backs Immunotherapy Company Biond Biologics

08.01.19|Meir Orbach
Biond develops immunotherapies for cancer and autoimmune diseases
אחות אחיות רפואה סיעוד

Novartis Invests $10 Million in Anti-Cancer Company Ayala Pharmaceuticals

24.12.18|Lilach Baumer
The investment is part of a licensing option agreement signed between the two companies
חקר DNA מעבדה

Lonza Opens Israeli Innovation Center

20.11.18|Lilach Baumer
The company announced plans for the center in 2017, stating it is looking to tap Israel's tech talent
default image

Israeli and French Biotech Companies Partner to Fight Diabetes With Bio-Artificial Pancreas

12.11.18|Lilach Baumer
Israel-based Kadimastem and France-headquartered Defymed will receive a grant of around $1.5 million from the European Commission's Eurostars program to develop the technology to treat type 1 diabetes
מוסף ניתוח מנתחים רופא רופאים חדר ניתוח

Biotech Company Polypid Raises $15 Million

07.11.18|Lilach Baumer
Israel-based Polypid develops encapsulating drug delivery technology that enables extended and localized release in the body
default image

Kadimastem Gets FDA Orphan Drug Designation for ALS Drug

04.11.18|Lilach Baumer
The biotech company is currently conducting an early clinical trial in Israel and expects results in mid-2019
תל אביב קו רקיע Tel Aviv Skyline

Israel to Help Biotech Companies Go from Research to Manufacturing

04.11.18|Omri Milman
Companies looking to set up manufacturing facilities could receive grants covering 20%-30% of the costs
מייקל היידן מחקר ו פיתוח טבע

Former Teva Executives Raise $60 Million for Metabolic Disorders Venture

28.10.18|Lilach Baumer
The company’s pipeline of biologic and small molecule drug candidates was acquired from Teva
נאסדק

Gamida Cell Downprices Shares to Raise $50 Million Nasdaq IPO

28.10.18|Lilach Baumer
The Israel-based biotech company offered its shares at $8, below its previous intention of $13 to $15 per share
קולפלנט דיו ביולוגי

Global Licensing and Commercialization Deal Catapults Collplant on Nasdaq

22.10.18|Lilach Baumer
The tissue regeneration company announced on Monday a deal with biotech company United Therapeutics and is currently up over 60% in pre-market trading
נאסד"ק וול סטריט

LogicBio Therapeutics Underperforms with $70 Million Nasdaq IPO

21.10.18|Lilach Baumer
Co-founded by Israel-born Adi Barzel, LogicBio develops genome-editing treatments for rare diseases
Previous ArticlesMore Articles